Marginal donors in liver transplantation

Hepato-Gastroenterology

Volumn 47, Issue 31, 2000, Pages 256-263

  Loinaz, Carmelo ^a   González, Enrique Moreno ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Liver transplantation; Marginal donors

Indexed keywords

ADULT; AGE; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; DONOR; FEMALE; HUMAN; HYPERNATREMIA; HYPOTENSION; ISCHEMIA; LIVER FUNCTION; LIVER TRANSPLANTATION; MALE; ORGAN DONOR; PRIORITY JOURNAL; REVIEW; SEPSIS; STEATOSIS; VIRUS INFECTION;

HUMANS; LIVER TRANSPLANTATION; RISK FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 0033951566     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. 1 Makowka L, Gordon RD, Todo S, et al: Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc 1987; 19:2378-2382.
2. 2 Mimeault R, Grant D, Ghent C, Duff J, Wall W: Analysis of donor and recipient variables and early graft function after orthotopic liver transplantation. Transplant Proc 1989; 21: p. 3355.
3. 3 Yanaga K, Tzakis AG, Starzl TE: Personal experience with the procurement of 132 liver allografts. Transpl Int 1989; 2:137-142.
4. 4 Greig PD, Forster J, Superina RA, et al: Donor-specific factors predict graft function following liver transplantation. Transplant Proc 1990; 22:2072-2073.
5. 5 Mor E, Klintmalm GB, Gonwa TA, et al: The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation 1992; 53:383-386.
6. 6 Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al: Malfunction of the liver after transplantation: an analysis of potential risk factors. Transplant Proc 1993; 25:1659-1661.
7. 7 Gruenberger T, Sautner T, Wamser P, Mittlböck M, Steininger R, Mülbbacher F: Impact of donor criteria on postoperative graft function in liver transplantation. Transplant Proc 1993; 25:3156-3157.
8. 8 González FX, Rimola A, Grande L, et al: Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 1994; 20:565-573.
9. 9 Maring JK, Klompmaker IJ, Zwaveling JH, Kranenburg K, Ten Vergert EM, Slooff MJH: Poor initial graft function after orthotopic liver transplantation: can it be predicted and does it affect outcome? An analysis of 125 adult primary transplantations. Clin Transplant 1997; 11:373-379.
10. 10 Teperman L, Podesta L, Mieles L, Starzl TE: The successful use of older donors for liver transplantation. JAMA 1989; 24: p. 2835. (Letter)
11. 11 Wall WJ, Mimeault R, Grant DR, Bloch MP: The use of older donor livers for hepatic transplantation. Transplantation 1990; 49:377-381.
12. 12 Grazi GL, Jovine E, Frena A, Grandi U, Belluschi R, Cavallari A, Mazziotti A, Gozzetti G: Influence of donor data on the outcome of liver transplantation. Transplant Proc 1991; 23:2483-2484.
13. 13 Alexander JW, Carey MA: The use of marginal donors for organ transplantation: the older and younger donors. Transplant Proc 1991; 23:905-909.
14. 14 Pirsch JD, Kalayoglu M, D'Alessandro, et al: Orthotopic liver transplantation in patients 60 years of age and older. Transplantation 1991; 51:431-433.
15. 15 Furukawa H, Todo S, Imvertanza O, et al: Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation 1991; 51:1000-1004.
16. 16 Adam R, Astarcioglu I, Azoulay D, et al: Age greater than 50 years is not a contraindication for liver donation. Transplant Proc 1991; 23:2602-2603.
17. 17 Adam R, Astarcioglu I, Azoulay D, et al: Liver transplantation from elderly donors. Transplant Proc 1993; 25:1556-1557.
18. 18 Gómez R, Moreno E, García I, et al: Resultados del trasplante hepático utilizando donantes de más de 50 años. Comparación con otros grupos de edad. Rev Esp Enf Digest 1993; 83:355-362.
19. 19 Post J, Miller CM, Schwartz ME, Kadian M: Is it safe to liberalize donor criteria to include those over age 60 and those weighing over 90 kg? Transplant Proc 1993; 25:1570.
20. 20 Grande L, González FX, Manterola C, et al: Does donor age exclude liver grafting? Transplant Proc 1993; 25:3151-3153.
21. 21 Bussuttil RW, Shaked A, Millis JM, et al: One thousand liver transplants. The lessons learned. Ann Surg 1994; 219:490-499.
22. 22 Gómez R, Moreno E, Loinaz C, et al: Trasplante hepático utilizando injertos de donantes de más de 65 años. Rev Esp Enf Digest 1995; 87:217-220.
23. 23 Yersiz H, Shaked A, Olthoff K, et al: Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation 1995;60:790-794.
24. 24 Marino IR, Doyle HR, Aldrighetti L, et al: Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995; 22:1754-1762.
25. 25 Washburn WK, Johnson LB, Lewis WD, Jenkins RL: graft function and outcome of older (>60 years) donor livers. Transplantation 1996; 61:1062-1066.
26. 26 Hoofnagle JH, Lombardero M, Zetterman RK, et al: Liver donor age and outcome of liver. Hepatology 1996; 24:89-96.
27. 27 Mor E, Shmueli D, Ben-Ari Z, et al: Liver allografts from donors older than 60: benefits and risks. Harefuah 1997; 132:681-684.
28. 28 Tisone G, Romagnoli J, Vennarecci, et al: Is donor age a risk factor for poor graft function after orthotopic liver transplantation. Transplant Proc 1997; 29:2825-2826.
29. 29 Grande L, Rull A, Rimola A, et al: Outcome of patients undergoing orthotopic liver transplantation with elderly donors (over 60 years). Transplant Proc 1997; 29:3289-3290.
30. 30 Strasberg SM, Howard TK, Molmenti EP, Hertl M: Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20:829-838.
31. 31 Kahn D, Gavaler JS, Makowka L, Starzl TE, Van Thiel DT: The gender of the donor influences the outcome after orthotopic liver transplantation. Hepatology 1988; 8:1225. (Abstract)
32. 32 Kahn D, Gavaler JS, Makowka L, Van Thiel DH: Gender of donor influences outcome after orthotopic liver transplantation in adults. Dig Dis Sci 1993; 38:1485-1488.
33. 33 Brooks BK, Levy MF, Jennings LW, et al: Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation 1996; 62:1784-1787.
34. 34 Brooks BK, Levy MF, Jennings LW, et al: Influence of donor and recipient gender on the outcome of liver transplantation. Transplant Proc 1997; 29:475-476.
35. 35 Pillay P, Van Thiel DH, Gavaler J, Starzl TE: Donor gender does not affect liver transplantation outcome in children. Dig Dis Sci 1990; 35:686-689.
36. 36 Kahn D, Zeng Q, Makowka L, et al: Orthotopic liver transplantation and the cytosolic estrogen-androgen receptor status of the liver: the influence of the sex of the donor. Hepatology 1989; 5:861-866.
37. 37 Candinas D, Gunson BK, Nightingale P, Hubscher S, McMaster P, Neuberger JM: Sex mismatch as a risk factor for chronic rejection of liver allografts. Lancet 1995; 346:1117-1121.
38. 38 Opelz G, Wujciak T: The influence of HLA compatibility on graft survival after heart transplantation. N Engl J Med 1994; 330:816-819.
39. 39 Avolio AW, Agnes S, Magalini SC, Castagneto M: Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome. Transplant Proc 1991: 23:2451-2452.
40. 40 Pruim J, van Woerden WF, Knol E, et al: Donor data in liver grafts with primary non-function - a preliminary analysis by the European Liver Registry. Transplant Proc 1989; 21:2383-2384.
41. 41 Adam R, Bismuth H, Diamond T, et al: Effect of extended cold ischemia with UW solution on graft function after liver transplantation. Lancet 1992; 340:1373-1376.
42. 42 Kakizoe S, Yanaga K, Starzl TE, et al: Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts. Considerations of preservation and early immunological injury. Hepatology 1990; 11:932-941.
43. 43 Adam R, Reynes M, Johann M, et al: The outcome of steatosic grafts in liver transplantation. Transplant Proc 1991; 23:1538-1540.
44. 44 D'Alessandro AM, Kalayoglu M, Sollinger HW, et al: The predictive value of donor liver biopsies for the development of primary non function after orthotopic liver transplantation. Transplantation 1991; 51:157-163.
45. 45 Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al: Risk factors for primary dysfunction after liver transplantation. A multivariate analysis. Transplantation 1993; 55:807-813.
46. 46 Markin RS, Wisecarver JL, Radio SJ, et al: Frozen section evaluation of donor livers before transplantation. Transplantation 1993; 56:1403-1409.
47. 47 Monsour HPJ, Wood RP, Ozaki C, et al: Utility of preoperative liver biopsy in live-related donor patients for liver transplantation. Transplant Proc 1994; 26:138-139.
48. 48 Karayalcin K, Mirza DF, Harrison RF, et al: The role of dynamic and morphological studies in the assessment of potential liver donors. Transplantation 1994; 57:1323-1327.
49. 49 Fishbein TM, Fiel MI, Emre S, et al: Use of livers with microvesicular fat safely expands the donor pool. Transplantation 1997; 64:248-251.
50. 50 Marsman WA, Wiesner RH, Rodríguez L, et al: Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996; 62:1246-1251.
51. 51 García MA, Colina F, Moreno E, et al: Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program. Transplant Proc 1998. (In press)
52. 52 Jiménez C, Moreno E, García I, et al: Successful transplantation of a liver graft with a calcified hydatid cyst after back-table resection. Transplantation 1995; 60:883-884.
53. 53 Bockhorn M, Broering DC, Rogiers X, Malagó M, Broelsch CE: Transplantation of traumatized livers-is it safe? Hepatogastroenterology 1998; 45:105. (Abstract)
54. 54 Nery JR, Weppler D, Ketchum P, et al: Donor infection and primary nonfunction in liver transplantation. Transplant Proc 1997; 29:481-483.
55. 55 González-Ruiz A, Pérrez G, Lumbreras C, et al: Importance of unrecognized donor bacteremia in determining the early outcome of solid organ transplant recipients. Presented at 37th ICAAC September 28-October 1, 1997; Toronto, Ontario. (Abstract)
56. 56 Chazouilléres O, Mamish D, Kim M, et al: "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343:142-146.
57. 57 Roche B, Samuel D, Gigou M, et al: De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol 1997; 26:517-526.
58. 58 Loinaz C, Lumbreras C, Domingo MJ, et al: Hepatitis B de novo en receptores de trasplante hepático. Presented at XI Reunión Nacional de la Asociación Espan̄ola de Cirujanos, November 4-8, 1997; Benalmádena, Málaga. (Abstract)
59. 59 Grazi GL, Pierangeli F, Jovine E, et al: De novo hepatitis B after liver transplantation. Hepatogastroenterology 1998; 45:104. (Abstract)
60. 60 Douglas DD, Rakela J, Mamish D, Wright TL, Krom RAF, Wiesner RH: Transmission of hepatitis B virus (HBV) infection from orthotopic donor livers. Hepatology 1992; 16:49A. (Abstract)
61. 61 Kadian M, Hawkins L, Nespral J, Schwartz M, Miller C: Use of hepatitis B core antibody positive multiorgan donors. Presented at the Second International Congress of the Society for Organ Sharing, British Columbia, 1993.
62. 62 Wachs ME, Amend WJ, Ascher N, et al: The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation 1995; 59:230-234.
63. 63 Dodson SF, Issa S, Araya V, et al: Infectivity of hepatic allografts with antobodies to hepatitis B virus. Transplantation 1997; 64:1582-1584.
64. 64 Pereira BJG, Milford EL, Kirkman RL, Levey AS: Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991; 325:454-460.
65. 65 Pereira BJG, Milford EL, Kirkman RL, et al: Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992; 327:910-915.
66. 66 Wreghitt TG, Gray JJ, Allain J-P, et al: Transmission of hepatitis C virus by organ transplantation in the United Kingdom. J Hepatol 1994; 20:768-772.
67. 67 Moreno E, García I, González-Pinto I, Gómez R, Loinaz C: Succesful re-use of a liver graft. Br J Surg 1991; 78:813-814.
68. 68 Moreno E, Gómez R, González-Pinto I, et al: Reuse of liver grafts after early death of the first recipient. World J Surg 1996; 20:309-313.
69. 69 Tantawi B, Cherqui D, Duvoux C, Dhumeaux D, Fagniez PL: Reuse of a liver graft five days after initial transplantation. Transplantation 1996; 62:868-869.
70. 70 Mirza DF, Gunson BK, Da Silva RF, Mayer AD, Buckels JAC, McMaster P: Policies in Europe on "marginal quality" donor livers. Lancet 1994; 344:1480-1483.
71. 71 Briceño J, López-Cillero P, Rufián, et al: Impact of marginal quality donors on the outcome of liver transplantation. Transplant Proc 1997; 29:477-480.
72. 72 Millis JM, Cronin DC II, Piper JB, et al: Impact of a liberalized donor acceptance policy on liver transplantation. Transplant Proc 1997; 29: p.484.
73. 73 Pruim J, Klompmaker IJ, Haagsma EB, Bijleveld CMA, Slooff MJH: Selection criteria for liver donation: a review. Transplant Int 1993; 6:226-235.